Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Sensitization of Resistant Cells with a BET Bromodomain Inhibitor in a Cell Culture Model of Deep Intrinsic Resistance in Breast Cancer

Cancers(2023)10.3390/cancers15072036Source: DataRank Database

Sensitization of Resistant Cells with a BET Bromodomain Inhibitor in a Cell Culture Model of Deep Intrinsic Resistance in Breast Cancer is a research paper published in Cancers (2023). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (2 grants)Impact (FWCI 0.55)OA: goldTopics (26)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Vanessa N. Sarli,Ryan D. Milligan,Hannah E. Kinne,Anna Shamsnia,Laura J. Washburn

Live enrichment

PubMed:37046697 PMC:PMC10093448 OpenAlex:https://openalex.org/W4361277486

United States Army Medical Command

Grant: DAMD17-03-1-0669 W81XWH-09-1-0590

United States Army Medical Command

Grant: P30CA016672

FWCI

0.55

Citation Percentile

0.6%

Citation Trend

2024

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/2072-6694/15/7/2036/pdf?version=1680084517

publisherhttps://www.mdpi.com/2072-6694/15/7/2036/pdf

journalhttps://doi.org/10.3390/cancers15072036

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37046697

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10093448

Fields of Study

Protein Degradation and InhibitorsUbiquitin and proteasome pathwaysMultiple Myeloma Research and Treatments

Keywords

BromodomainSensitizationCancer researchBET inhibitorMedicineCancerBreast cancerBiologyInternal medicineImmunologyEpigeneticsGeneBiochemistryPD-L1Inflammatory Breast CancerMinimal Residual DiseaseJq1Intrinsic ResistanceCell Culture ModelMetastasis PreventionCancer EpigenomeCancer RelapseCancer Quiescence

Sustainable Development Goals

SDG 0: Good health and well-being